Cardiovascular risk equations in type 1 diabetes: from generic models to personalized prediction

Area of Science:

• Cardiology
• Endocrinology
• Preventive Medicine

Background:

• Cardiovascular disease (CVD) is the primary cause of premature death in type 1 diabetes (T1D).
• Existing risk assessment tools are often derived from type 2 diabetes or general populations, inadequately addressing T1D-specific atherosclerosis drivers.
• Current clinical guidelines for T1D cardiovascular risk management are inconsistent.

Purpose of the Study:

• To critically review current cardiovascular prevention strategies in T1D.
• To identify limitations of generic cardiovascular risk calculators in T1D.
• To analyze the performance of T1D-specific risk equations.

Main Methods:

• Narrative review of existing literature and risk stratification models.
• Comparison of generic risk calculators (e.g., SCORE2, ACC/AHA) with T1D-specific equations (e.g., Steno-Risk, LIFE-T1D).
• Evaluation of discriminatory performance and clinical utility of different risk models.

Main Results:

• Generic risk calculators show poor performance and short prediction horizons in T1D cohorts.
• T1D-specific equations incorporating diabetes duration and albuminuria demonstrate superior risk discrimination.
• Even T1D-specific models may misclassify patients with subclinical atherosclerosis as moderate risk.

Conclusions:

• Generic risk algorithms are insufficient for T1D cardiovascular risk assessment.
• T1D-specific equations are an improvement but may not be sufficient alone.
• Precision medicine requires integrating T1D risk calculators with subclinical atherosclerosis screening and novel biomarkers for individualized care.